Thoracic Cancer is the cancer in the thoracic cavity. It mainly includes lung and oesophageal cancer. The Multi-disciplinary team brings together the team of experts to provide an exceptional patient care for those diagnosed with tumours or cancer of the chest.
Statistics of Lung Cancer
Lung cancer has been the most common cancer overall for several decades. In 2012, worldwide, there are estimated to have been 1.8 million new cases (12.9% of all incident cancer cases), 58% of which occurred in the less developed regions. The disease remains the most common cancer in men worldwide, with 1.2 million cases estimated to have occurred in men in 2012 (16.7% of the total number of all incident cancer cases in men). Lung cancer is also the most common cause of death from cancer worldwide, estimated to be responsible for nearly 1 in 5 cancer deaths (1.59 million deaths, 19.4% of the total number of cancer deaths in 2012). Because of lung cancer’s high rate of fatality (the overall ratio of mortality to incidence is 0.87) and the relative lack of variability in survival in different world regions, the geographical patterns in lung cancer mortality closely follow those in lung cancer incidence.
APCC has comprehensive diagnostic, therapeutic and supportive treatments all under one roof to care for a patient of lung cancer.
The growing burden of cancer across the globe tells an ominous tale. To counter this growing threat, Apollo Hospitals introduces Proton Beam therapy with focused cancer management teams that will provide optimal solutions like never before. We believe it is critical to redefine our purpose, to reboot our commitment on the single-minded focus to win over cancer. APCC stands as a ray of hope for millions of patients as they join us in the battle to win over cancer.